Stevens Capital Management LP purchased a new stake in Envision Healthcare Corporation (NYSE:EVHC) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 59,284 shares of the company’s stock, valued at approximately $2,665,000. Stevens Capital Management LP owned approximately 0.05% of Envision Healthcare Corporation at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of EVHC. Janus Henderson Group PLC boosted its stake in shares of Envision Healthcare Corporation by 36,086.8% in the second quarter. Janus Henderson Group PLC now owns 3,945,087 shares of the company’s stock valued at $247,239,000 after buying an additional 3,934,185 shares in the last quarter. Maverick Capital Ltd. boosted its stake in shares of Envision Healthcare Corporation by 66.2% in the second quarter. Maverick Capital Ltd. now owns 5,093,292 shares of the company’s stock valued at $319,197,000 after buying an additional 2,028,026 shares in the last quarter. Lord Abbett & CO. LLC boosted its stake in shares of Envision Healthcare Corporation by 259.6% in the second quarter. Lord Abbett & CO. LLC now owns 1,321,328 shares of the company’s stock valued at $82,808,000 after buying an additional 953,928 shares in the last quarter. Westfield Capital Management Co. LP purchased a new stake in shares of Envision Healthcare Corporation in the second quarter valued at approximately $45,892,000. Finally, American Century Companies Inc. purchased a new stake in shares of Envision Healthcare Corporation in the second quarter valued at approximately $31,861,000.

COPYRIGHT VIOLATION WARNING: This story was first reported by Watch List News and is the property of of Watch List News. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this story can be viewed at https://www.watchlistnews.com/stevens-capital-management-lp-invests-2-67-million-in-envision-healthcare-corporation-evhc/1695572.html.

Shares of Envision Healthcare Corporation (NYSE EVHC) opened at $24.95 on Friday. The company has a debt-to-equity ratio of 0.89, a current ratio of 3.01 and a quick ratio of 3.00. Envision Healthcare Corporation has a 12-month low of $24.45 and a 12-month high of $74.75. The stock has a market capitalization of $3,110.48, a price-to-earnings ratio of 7.94, a PEG ratio of 0.67 and a beta of 0.69.

Envision Healthcare Corporation (NYSE:EVHC) last released its earnings results on Tuesday, October 31st. The company reported $0.73 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.81 by ($0.08). The business had revenue of $1.99 billion during the quarter, compared to analyst estimates of $2.03 billion. Envision Healthcare Corporation had a negative net margin of 6.39% and a positive return on equity of 4.88%. The business’s revenue for the quarter was up 142.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.13 earnings per share. sell-side analysts anticipate that Envision Healthcare Corporation will post 2.56 EPS for the current fiscal year.

Envision Healthcare Corporation declared that its board has approved a stock buyback plan on Monday, September 18th that allows the company to repurchase $250.00 million in shares. This repurchase authorization allows the company to purchase up to 4.5% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s management believes its stock is undervalued.

A number of analysts recently weighed in on EVHC shares. Bank of America Corporation decreased their price target on Envision Healthcare Corporation from $72.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, October 9th. Mizuho set a $57.00 price target on Envision Healthcare Corporation and gave the company a “hold” rating in a research note on Tuesday, October 31st. Zacks Investment Research downgraded Envision Healthcare Corporation from a “hold” rating to a “strong sell” rating in a research note on Tuesday, October 24th. Citigroup Inc. downgraded Envision Healthcare Corporation from a “buy” rating to a “neutral” rating and set a $31.00 target price on the stock. in a research report on Thursday, November 2nd. Finally, SunTrust Banks, Inc. set a $55.00 target price on Envision Healthcare Corporation and gave the stock a “buy” rating in a research report on Sunday, October 15th. Two analysts have rated the stock with a sell rating, five have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $49.21.

Envision Healthcare Corporation Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Corporation (NYSE:EVHC).

Institutional Ownership by Quarter for Envision Healthcare Corporation (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.